Dark
Light
Today: January 4, 2026

Adrian Johnson

Metsera Unveils $290M Investment Boost

TLDR: Metsera, a NYC-based clinical-stage biopharmaceutical company, raised $290M in funding. The round was led by ARCH Venture Partners with participation from other healthcare investors. Metsera, a clinical-stage biopharmaceutical company, has launched
April 19, 2024
1 432 433 434 435 436 679
Go toTop